People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

Decreasing CD4 and lymphocyte counts in some participants receiving an oral combination therapy led to holds in the study.

HALIFAX – Nova Scotia physicians and other sexual health experts who are calling on the provincial government to fund birth ...

Walmart's Flipkart has secured a lending licence from the Indian central bank and banking regulator, enabling it to offer ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

Roughly $12 million worth of HIV-prevention drugs and contraceptives purchased by the U.S. Agency for International ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.